Together, we believe our wealth of experience and scientific expertise will allow us to deliver on the promise of our novel targeted nucleic acid delivery platform, helping to transform outcomes for patients everywhere.
Peter Braun
Chief Executive Officer
Andrew Oakley
Chief Financial Officer
Dr. Fermin Ruiz de Erenchun
Chief Operating Officer
Dr. Esteban Pombo-Villar, PhD
Chief Technology Officer
Dr. Maya Zigler, PhD
Head of Research
Marc Thommen
Head of Technical Development
Babette Güldenpfennig
Head of Business Development
Catherine Ammann
Chief People Officer
Bruno Heynen
General Counsel
Dr. Kuno Sommer, PhD
Chairman of the Board
Dr. Peter Kash, EdD, MBA
Vice Chairman, Co-founder
Prof. Alex Levitzki, PhD
Board Member, Co- Founder/Co-Inventor
Paolo Fundarò
Board Member
Christoph Rentsch
Co-founder, Board Member